Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 6: Frontiers in Small Molecule Drug Discovery

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Inhibitors of the HSF1 stress pathway derived from phenotypic screening: Targeting non-oncogene addiction in ovarian and other cancers
Paul Workman
The Institute of Cancer Research, London, United Kingdom
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 10:00 AM-11:45 AM
Discovery of BI-3406: a potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors
Marco H Hofmann
Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 10:00 AM-11:45 AM
ALK2 open drug discovery: A development path from genes to affordable medicines in DIPG
Aled Edwards
Structural Genomics Consortium, Toronto, ON, Canada
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 10:00 AM-11:45 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3